GEN Exclusives

More »

The Lists

More »
Apr 2, 2013

Top 22 R&D Spenders among Tool and Technologies Companies

Find out how much money goes into developing the instruments you use for research.

Top 22 R&D Spenders among Tool and Technologies Companies

These tool and tech providers are investing the most in R&D among those in the biotechnology arena. [Natalia Merzlyakova - Fotolia.com]

  • #11. Danaher Life Sciences & Diagnostics4

    2012 R&D spending: $418 million

    2011 R&D spending: $341 million

    % Change: 22.6%

    2012 percentage of sales: 6.5%

    2011 percentage of sales: 7.3%

  • #10. Bruker

    2012 R&D spending: $195.3 million

    2011 R&D spending: $177.2 million

    % Change: 10.2%

    2012 percentage of revenues: 10.9%

    2011 percentage of revenues: 10.7%

  • #9. Merck Millipore5

    2012 R&D spending: $212.890 million (€166.1 million)6

    2011 R&D spending: $170.978 million (€133.4 million)6,7

    % Change: 24.5%

    2012 percentage of sales: 6.4%

    2011 percentage of sales: 5.6%

  • #8. Bio-Rad Laboratories

    2012 R&D spending: $214.040 million

    2011 R&D spending: $186.439 million

    % Change: 14.8%

    2012 percentage of net sales: 10.3%

    2011 percentage of net sales: 9.0%

  • #7. Illumina

    2012 R&D spending: $231.025 million

    2011 R&D spending: $196.913 million

    % Change: 17.3%

    2012 percentage of revenues: 20.1%

    2011 percentage of revenues: 18.7%

  • #6. Thermo Fisher Scientific

    2012 R&D spending: $376.4 million

    2011 R&D spending: $340.2 million

    % Change: 10.6%

    2012 percentage of revenues: 3.0%

    2011 percentage of revenues: 2.9%

  • #5. Life Technologies

    2012 R&D spending: $341.892 million

    2011 R&D spending: $377.924 million

    % Change: -9.5%

    2012 percentage of revenues: 9.0%

    2011 percentage of revenues: 10.0%

  • #4. Becton Dickinson (BD)

    2012 R&D spending: $471.755 million8

    2011 R&D spending: $469.517 million8

    % Change: 0.5%

    2012 percentage of revenues: 6.1%

    2011 percentage of revenues: 6.2%

  • #3. Agilent Technologies

    2012 R&D spending: $668 million9

    2011 R&D spending: $649 million9

    % Change: 2.9%

    2012 percentage of net revenues: 9.7%

    2011 percentage of net revenues: 9.5%

  • #2. GE Healthcare10

    2012 R&D spending: Approx. $1 billion11

    2011 R&D spending: Approx. $1 billion11

    % Change: No change

    2012 percentage of revenues: about 5.5%

    2011 percentage of revenues: about 5.5%

  • #1. Roche - Diagnostics Division12

    2012 R&D spending: $1.078 billion (CHF 1.023 billion)13

    2011 R&D spending: $978.914 million (CHF 929 million)13

    % Change: 10.1%

    2012 percentage of sales: 10.0%

    2011 percentage of sales: 9.5%


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Stopping Research Fraud

What is the best approach to curbing scientific misconduct and outright fraud?